Amniotic Membrane Market Size To Reach $8.50 Billion By 2030

Amniotic Membrane Market Growth & Trends

The global amniotic membrane market size is expected to reach USD 8.50 billion by 2030, registering a CAGR of 13.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. Global rise in the number of trauma and burn cases, surgeries, and increasing cognizance regarding various benefits offered by amniotic membrane-based products are factors increasing their demand. Amniotic membrane has pain-reducing properties, which may lead to the increased adoption of these tissue-based products in surgical wounds and ophthalmology.

Also, rising expenditure in R&D in the field of stem cells and regenerative medicine and the rising number of surgeries being performed are some of the key factors anticipated to augment the market growth. The global market is expected to gain potential owing to a wide range of product applications in ophthalmology, skin, brain, and head & neck, genitourinary tract, as well as other surgical procedures. In addition, the rise in amniotic membrane-based transplantations across the globe is predicted to fuel the overall market growth. Moreover, rising awareness regarding the product benefits among healthcare professionals as well as individuals is estimated to boost the demand over the forecast years.

However, the dearth of skilled professionals is expected to impede market growth. Amniotic membrane-based products are most commonly used in the treatment of various areas, such as venous, pressure, and diabetic foot ulcers, ophthalmology, surgeries, and also in the management of chronic wounds. Moreover, with increasing research in the field of stem cell research and regenerative medicine, various research and academic institutes are engaged in a study to facilitate the usage of these products for other applications.

 Request a free sample copy or view report summary: Amniotic Membrane Market Report

Amniotic Membrane Market Report Highlights

• The cryopreserved amniotic membrane segment held the largest revenue share of more than 50.0% in 2022 owing to the high effectivity and preservation of histological and biological properties in these membranes

• The surgical wounds segment accounted for the maximum revenue share of 36.7% in 2022 due to the increased volume of surgical procedures and wide product usage in surgical applications

•  Specialty clinics are anticipated to gain the highest market share by 2030 due to the increasing number of cosmetic and reconstructive surgeries being performed globally

• North America dominated the market in 2022 with a revenue share of 31.7% owing to the existence of a large number of major players and the high incidence of chronic and infectious diseases

• Asia Pacific is expected to grow at the fastest CAGR of 14.5% during the forecast period due to the high population coupled with the rising chronic diseases and burn incidences

Amniotic Membrane Market Segmentation

Grand View Research has segmented the global amniotic membrane market on the basis of product, application, end-use, and region:

Amniotic Membrane Product Outlook (Revenue, USD Million, 2018 - 2030)

• Cryopreserved

• Dehydrated

Amniotic Membrane Application Outlook (Revenue, USD Million, 2018 - 2030)

• Surgical Wounds

• Ophthalmology

• Others

Amniotic Membrane End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Specialty Clinics

• Research And Academic Institutes

Amniotic Membrane Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players of Amniotic Membrane Market

• Alliqua BioMedical Inc.

• Amnio Technology, LLC

• Applied Biologics LLC

• Human Regenerative Technologies, LLC

• DermaSciences

• Katena Products, Inc.

• MiMedx Group Inc.

• Skye Biologics, Inc.

• Amniox Medical Inc.

• Organogensis, Inc.